Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma. | Front Oncol | 2022 | 36698400 | PubTator, text mining | PubMed |
| Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research. | Front Oncol | 2022 | 36698398 | PubTator, text mining | PubMed |
| The Phylogeny, Ontogeny, and Organ-specific Differentiation of Macrophages in the Developing Intestine. | Newborn (Clarksville) | 2022 | 36698382 | PubTator, text mining | PubMed |
| Macrophage scavenger receptors: Tumor support and tumor inhibition. | Front Oncol | 2022 | 36686729 | PubTator, text mining | PubMed |
| Stem Cell Therapy for Acute/Subacute Ischemic Stroke with a Focus on Intraarterial Stem Cell Transplantation: From Basic Research to Clinical Trials. | Bioengineering (Basel) | 2022 | 36671605 | PubTator, text mining | PubMed |
| Genipin Attenuates Diabetic Cognitive Impairment by Reducing Lipid Accumulation and Promoting Mitochondrial Fusion via FABP4/Mfn1 Signaling in Microglia. | Antioxidants (Basel) | 2022 | 36670935 | PubTator, text mining | PubMed |
| Preliminary Study of Genome-Wide Association Identified Novel Susceptibility Genes for Hemorheological Indexes in a Chinese Population. | Transfus Med Hemother | 2022 | 36654975 | PubTator, text mining | PubMed |
| Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso. | Prostate Cancer | 2022 | 36643816 | PubTator, text mining | PubMed |
| Resting time after phorbol 12-myristate 13-acetate in THP-1 derived macrophages provides a non-biased model for the study of NLRP3 inflammasome. | Front Immunol | 2022 | 36618426 | PubTator, text mining | PubMed |
| Microarray Expression Profile of Myricetin-Treated THP-1 Macrophages Exhibits Alterations in Atherosclerosis-Related Regulator Molecules and LXR/RXR Pathway. | Int J Mol Sci | 2022 | 36613720 | PubTator, text mining | PubMed |
| Novel approach to artefact detection and the definition of normal ranges of segmental strain and strain-rate values. | Open Heart | 2022 | 36600649 | PubTator, text mining | PubMed |
| The immune landscape of high-grade brain tumor after treatment with immune checkpoint blockade. | Front Immunol | 2022 | 36591276 | PubTator, text mining | PubMed |
| Role of macrophage scavenger receptor MSR1 in the progression of non-alcoholic steatohepatitis. | Front Immunol | 2022 | 36591228 | PubTator, text mining | PubMed |
| Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis. | Front Immunol | 2022 | 36582238 | PubTator, text mining | PubMed |
| The sirtuin family in health and disease. | Signal Transduct Target Ther | 2022 | 36581622 | PubTator, text mining | PubMed |
| Worldwide productivity and research trend of publications concerning glioma-associated macrophage/microglia: A bibliometric study. | Front Neurol | 2022 | 36570441 | PubTator, text mining | PubMed |
| Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties. | Pharmaceutics | 2022 | 36559202 | PubTator, text mining | PubMed |
| Photodynamic Therapy with Nebulized Nanocurcumin on A549 Cells, Model Vessels, Macrophages and Beyond. | Pharmaceutics | 2022 | 36559132 | PubTator, text mining | PubMed |
| Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System. | Pharmaceutics | 2022 | 36559099 | PubTator, text mining | PubMed |
| Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies. | J Clin Med | 2022 | 36555946 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=35